Risk factors for total and cause-specific mortality in human cardiac transplantation. Prolonged extracorporeal bypass time: a high risk factor for rejection and infection.
Data from the first 103 human heart transplantations in 100 recipients performed at a single centre from November 1983 to January 1990 were analysed to detect risk factors for overall and cause-specific mortality. Twenty-two patients died. Cumulative 1 year graft survival was 82% and 5 year, 68%. Acute and chronic rejection was the cause of death in 9 patients, disseminated infection in 8 and cancer in 3. One patient died from cerebral haemorrhage and 1 from acute cardiac failure. The mean observation time was 803 days (range: 1-2 308 days). Total follow-up was 226.6 graft years. Risk factors were analysed by univariate and multivariate methods. The type of immunosuppression regimen and recipient age above 50 years were independent risk factors for mortality. Histocompatibility mismatching (HLA-DR) and type of immunosuppression were independent risk factors for lethal rejection and a female recipient was an independent risk factor for lethal infection. Prolonged time on extracorporeal bypass was an independent risk factor for both lethal rejection and infection, and also for overall mortality. The impact of extracorporeal bypass time on rejection and infection is discussed, and the importance of prospective HLA matching in heart transplantation is stressed. The association between recipient female sex and infection remains uncertain.
Foerster
A
A
Department of Pathology, National Hospital of Norway, Oslo.
Abdelnoor
M
M
Geiran
O
O
Lindberg
H
H
Simonsen
S
S
Thorsby
E
E
Frøysaker
T
T
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002423:Cause of Death; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000276:immunology; D016027:Heart Transplantation; D006650:Histocompatibility Testing / Q000592:standards; D006773:Hospitals, Municipal; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards; D007239:Infections / Q000209:etiology / Q000276:immunology / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D011183:Postoperative Complications / Q000209:etiology / Q000276:immunology / Q000401:mortality*; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors